Europe artificial organ and bionics market was valued at $7.86 billion in 2022 and will grow by 8.0% annually over 2022-2032. The growth is driven by a rising incidence of organ failure due to lifestyle disorders and road accidents, scarcity of organ donors, increase in geriatric population, technological advancements in healthcare, the availability of cutting-edge artificial support systems, favorable reimbursement policies, and the increasing FDA approvals for implants.
Highlighted with 36 tables and 64 figures, this 126-page report 鈥淓urope Artificial Organ and Bionics 麻豆原创 2022-2032 by Product Type (Organ, Bionics), Material (Metals, Polymers, Ceramics), Technology (Mechanical, Electronic), Fixation Type (Implantable, Wearable), Age Group (up to 17, 18-34, 35-49, 50-64, 65+), End User (Hospitals, ASCs, Others), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe artificial organ and bionics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe artificial organ and bionics market in every aspect of the classification from perspectives of Product Type, Material, Technology, Fixation Type, Age Group, End User, and Country.
Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Artificial Organ
o Kidney
o Heart
o Liver
o Lungs
o Pancreas
o Other Organs
鈥� Artificial Bionics
o Ear Bionics
o Exoskeleton
o Bionic Limbs
o Vision Bionics
o Brain Bionics
o Cardiac Bionics
o Other Bionics
Based on Material, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Metals
鈥� Polymers
鈥� Ceramics
鈥� Other Materials
By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Mechanical
鈥� Electronic
By Fixation Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Implantable
鈥� Wearable
By Fixation Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� 17 Years Old and Under
鈥� 18-34 Years Old
鈥� 35-49 Years Old
鈥� 50-64 Years Old
鈥� 65 Years Old and Above
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
鈥� Hospitals
鈥� Ambulatory Surgical Centers (ASCs)
鈥� Other End Users
Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Netherlands
鈥� Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Product Type, Technology, and End User over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
Abiomed, Inc.
Berlin Heart GmbH
Biomet Inc.
Boston Scientific Corporation
Cochlear Ltd.
Edward Lifesciences Corporation
Ekso Bionics Holdings, Inc.
Iwalk Inc.
Jarvik Heart, Inc.
Medtronic Plc
脰ssur hf.
ReWalk Robotics Ltd.
SynCardia Systems LLC
Zimmer Biomet Holdings Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 23
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 25
2.2 Major Growth Drivers 29
2.3 麻豆原创 Restraints and Challenges 33
2.4 Emerging Opportunities and 麻豆原创 Trends 36
2.5 Porter鈥檚 Fiver Forces Analysis 40
3 Segmentation of Europe 麻豆原创 by Product Type 44
3.1 麻豆原创 Overview by Product Type 44
3.2 Artificial Organ 46
3.2.1 Kidney 48
3.2.2 Heart 49
3.2.3 Liver 50
3.2.4 Lungs 51
3.2.5 Pancreas 52
3.2.6 Other Organs 53
3.3 Artificial Bionics 54
3.3.1 Ear Bionics 56
3.3.2 Exoskeleton 57
3.3.3 Bionic Limbs 58
3.3.4 Vision Bionics 59
3.3.5 Brain Bionics 60
3.3.6 Cardiac Bionics 61
3.3.7 Other Bionics 62
4 Segmentation of Europe 麻豆原创 by Material 63
4.1 麻豆原创 Overview by Material 63
4.2 Metals 65
4.3 Polymers 66
4.4 Ceramics 67
4.5 Other Materials 68
5 Segmentation of Europe 麻豆原创 by Technology 69
5.1 麻豆原创 Overview by Technology 69
5.2 Mechanical 71
5.3 Electronic 72
6 Segmentation of Europe 麻豆原创 by Fixation Type 73
6.1 麻豆原创 Overview by Fixation Type 73
6.2 Implantable 75
6.3 Wearable 76
7 Segmentation of Europe 麻豆原创 by Age Group 77
7.1 麻豆原创 Overview by Age Group 77
7.2 17 Years Old and Under 79
7.3 18-34 Years Old 80
7.4 35-49 Years Old 81
7.5 50-64 Years Old 82
7.6 65 Years Old and Above 83
8 Segmentation of Europe 麻豆原创 by End User 84
8.1 麻豆原创 Overview by End User 84
8.2 Hospitals 86
8.3 Ambulatory Surgical Centers (ASCs) 87
8.4 Other End Users 88
9 European 麻豆原创 2022-2032 by Country 89
9.1 Overview of European 麻豆原创 89
9.2 Germany 92
9.3 U.K. 94
9.4 France 96
9.5 Spain 98
9.6 Italy 100
9.7 Netherlands 102
9.8 Rest of European 麻豆原创 104
10 Competitive Landscape 106
10.1 Overview of Key Vendors 106
10.2 New Product Launch, Partnership, Investment, and M&A 109
10.3 Company Profiles 110
Abbott Laboratories Inc. 110
Abiomed, Inc. 112
Berlin Heart GmbH 113
Biomet Inc. 114
Boston Scientific Corporation 115
Cochlear Ltd. 116
Edward Lifesciences Corporation 117
Ekso Bionics Holdings, Inc. 118
Iwalk Inc. 119
Jarvik Heart, Inc. 120
Medtronic Plc 121
脰ssur hf. 122
ReWalk Robotics Ltd. 123
SynCardia Systems LLC 124
Zimmer Biomet Holdings Inc. 125
RELATED REPORTS 126
List of Tables:
Table 1. Snapshot of Europe Artificial Organ and Bionics 麻豆原创 in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. Scenarios for Economic Impact of Ukraine Crisis 26
Table 5. Main Product Trends and 麻豆原创 Opportunities in Europe Artificial Organ and Bionics 麻豆原创 36
Table 6. Europe Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 44
Table 7. Europe Artificial Organ and Bionics 麻豆原创: Artificial Organ by Type, 2022-2032, $ mn 47
Table 8. Europe Artificial Organ and Bionics 麻豆原创: Artificial Bionics by Type, 2022-2032, $ mn 55
Table 9. Europe Artificial Organ and Bionics 麻豆原创 by Material, 2022-2032, $ mn 63
Table 10. Europe Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 69
Table 11. Europe Artificial Organ and Bionics 麻豆原创 by Fixation Type, 2022-2032, $ mn 73
Table 12. Europe Artificial Organ and Bionics 麻豆原创 by Age Group, 2022-2032, $ mn 77
Table 13. Europe Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 84
Table 14. Europe Artificial Organ and Bionics 麻豆原创 by Country, 2022-2032, $ mn 91
Table 15. Germany Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 93
Table 16. Germany Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 93
Table 17. Germany Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 93
Table 18. U.K. Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 95
Table 19. U.K. Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 95
Table 20. U.K. Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 95
Table 21. France Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 97
Table 22. France Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 97
Table 23. France Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 97
Table 24. Spain Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 99
Table 25. Spain Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 99
Table 26. Spain Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 99
Table 27. Italy Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 101
Table 28. Italy Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 101
Table 29. Italy Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 101
Table 30. Netherlands Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, $ mn 103
Table 31. Netherlands Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, $ mn 103
Table 32. Netherlands Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, $ mn 103
Table 33. Artificial Organ and Bionics 麻豆原创 in Rest of Europe by Country, 2022-2032, $ mn 105
Table 34. Abbott Laboratories Inc.: Company Snapshot 110
Table 35. Abbott Laboratories Inc.: Business Segmentation 111
Table 36. Abbott Laboratories Inc.: Product Portfolio 111
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for 麻豆原创 Estimation 14
Figure 3. Europe 麻豆原创 Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 16
Figure 4. Europe Artificial Organ and Bionics 麻豆原创, 2022-2032, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Artificial Organ and Bionics 麻豆原创 29
Figure 7. Overview of Worldwide Organ Donation and Transplant, 2021 32
Figure 8. Estimated Number of Worldwide Organ Transplants by Organ Type in 2021 32
Figure 9. Primary Restraints and Impact Factors of Europe Artificial Organ and Bionics 麻豆原创 33
Figure 10. Investment Opportunity Analysis 37
Figure 11. Porter鈥檚 Fiver Forces Analysis of Europe Artificial Organ and Bionics 麻豆原创 40
Figure 12. Breakdown of Europe Artificial Organ and Bionics 麻豆原创 by Product Type, 2022-2032, % of Revenue 45
Figure 13. Europe Addressable 麻豆原创 Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%) 45
Figure 14. Europe Artificial Organ and Bionics 麻豆原创 by Product Type: Artificial Organ, 2022-2032, $ mn 46
Figure 15. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Organ: Kidney, 2022-2032, $ mn 48
Figure 16. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Organ: Heart, 2022-2032, $ mn 49
Figure 17. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Organ: Liver, 2022-2032, $ mn 50
Figure 18. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Organ: Lungs, 2022-2032, $ mn 51
Figure 19. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Organ: Pancreas, 2022-2032, $ mn 52
Figure 20. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Organ: Other Organs, 2022-2032, $ mn 53
Figure 21. Europe Artificial Organ and Bionics 麻豆原创 by Product Type: Artificial Bionics, 2022-2032, $ mn 54
Figure 22. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Ear Bionics, 2022-2032, $ mn 56
Figure 23. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Exoskeleton, 2022-2032, $ mn 57
Figure 24. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Bionic Limbs, 2022-2032, $ mn 58
Figure 25. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Vision Bionics, 2022-2032, $ mn 59
Figure 26. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Brain Bionics, 2022-2032, $ mn 60
Figure 27. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Cardiac Bionics, 2022-2032, $ mn 61
Figure 28. Europe Artificial Organ and Bionics 麻豆原创 by Artificial Bionics: Other Bionics, 2022-2032, $ mn 62
Figure 29. Breakdown of Europe Artificial Organ and Bionics 麻豆原创 by Material, 2022-2032, % of Sales Revenue 64
Figure 30. Europe Addressable 麻豆原创 Cap in 2023-2032 by Material, Value ($ mn) and Share (%) 64
Figure 31. Europe Artificial Organ and Bionics 麻豆原创 by Material: Metals, 2022-2032, $ mn 65
Figure 32. Europe Artificial Organ and Bionics 麻豆原创 by Material: Polymers, 2022-2032, $ mn 66
Figure 33. Europe Artificial Organ and Bionics 麻豆原创 by Material: Ceramics, 2022-2032, $ mn 67
Figure 34. Europe Artificial Organ and Bionics 麻豆原创 by Material: Other Materials, 2022-2032, $ mn 68
Figure 35. Breakdown of Europe Artificial Organ and Bionics 麻豆原创 by Technology, 2022-2032, % of Sales Revenue 70
Figure 36. Europe Addressable 麻豆原创 Cap in 2023-2032 by Technology, Value ($ mn) and Share (%) 70
Figure 37. Europe Artificial Organ and Bionics 麻豆原创 by Technology: Mechanical, 2022-2032, $ mn 71
Figure 38. Europe Artificial Organ and Bionics 麻豆原创 by Technology: Electronic, 2022-2032, $ mn 72
Figure 39. Breakdown of Europe Artificial Organ and Bionics 麻豆原创 by Fixation Type, 2022-2032, % of Revenue 74
Figure 40. Europe Addressable 麻豆原创 Cap in 2023-2032 by Fixation Type, Value ($ mn) and Share (%) 74
Figure 41. Europe Artificial Organ and Bionics 麻豆原创 by Fixation Type: Implantable, 2022-2032, $ mn 75
Figure 42. Europe Artificial Organ and Bionics 麻豆原创 by Fixation Type: Wearable, 2022-2032, $ mn 76
Figure 43. Breakdown of Europe Artificial Organ and Bionics 麻豆原创 by Age Group, 2022-2032, % of Revenue 78
Figure 44. Europe Addressable 麻豆原创 Cap in 2023-2032 by Age Group, Value ($ mn) and Share (%) 78
Figure 45. Europe Artificial Organ and Bionics 麻豆原创 by Age Group: 17 Years Old and Under, 2022-2032, $ mn 79
Figure 46. Europe Artificial Organ and Bionics 麻豆原创 by Age Group: 18-34 Years Old, 2022-2032, $ mn 80
Figure 47. Europe Artificial Organ and Bionics 麻豆原创 by Age Group: 35-49 Years Old, 2022-2032, $ mn 81
Figure 48. Europe Artificial Organ and Bionics 麻豆原创 by Age Group: 50-64 Years Old, 2022-2032, $ mn 82
Figure 49. Europe Artificial Organ and Bionics 麻豆原创 by Age Group: 65 Years Old and Above, 2022-2032, $ mn 83
Figure 50. Breakdown of Europe Artificial Organ and Bionics 麻豆原创 by End User, 2022-2032, % of Revenue 84
Figure 51. Europe Addressable 麻豆原创 Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 85
Figure 52. Europe Artificial Organ and Bionics 麻豆原创 by End User: Hospitals, 2022-2032, $ mn 86
Figure 53. Europe Artificial Organ and Bionics 麻豆原创 by End User: Ambulatory Surgical Centers (ASCs), 2022-2032, $ mn 87
Figure 54. Europe Artificial Organ and Bionics 麻豆原创 by End User: Other End Users, 2022-2032, $ mn 88
Figure 55. Breakdown of European Artificial Organ and Bionics 麻豆原创 by Country, 2022 and 2032, % of Revenue 90
Figure 56. Contribution to Europe 2023-2032 Cumulative 麻豆原创 by Country, Value ($ mn) and Share (%) 91
Figure 57. Artificial Organ and Bionics 麻豆原创 in Germany, 2022-2032, $ mn 92
Figure 58. Artificial Organ and Bionics 麻豆原创 in U.K., 2022-2032, $ mn 94
Figure 59. Artificial Organ and Bionics 麻豆原创 in France, 2022-2032, $ mn 96
Figure 60. Artificial Organ and Bionics 麻豆原创 in Spain, 2022-2032, $ mn 98
Figure 61. Artificial Organ and Bionics 麻豆原创 in Italy, 2022-2032, $ mn 100
Figure 62. Artificial Organ and Bionics 麻豆原创 in Netherlands, 2022-2032, $ mn 102
Figure 63. Artificial Organ and Bionics 麻豆原创 in Rest of Europe, 2022-2032, $ mn 104
Figure 64. Growth Stage of Europe Artificial Organ and Bionics Industry over the Forecast Period 106
Selected Key Players:
Abbott Laboratories Inc.
Abiomed, Inc.
Berlin Heart GmbH
Biomet Inc.
Boston Scientific Corporation
Cochlear Ltd.
Edward Lifesciences Corporation
Ekso Bionics Holdings, Inc.
Iwalk Inc.
Jarvik Heart, Inc.
Medtronic Plc
脰ssur hf.
ReWalk Robotics Ltd.
SynCardia Systems LLC
Zimmer Biomet Holdings Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.
